| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.63B | 38.49B | 39.22B | 38.91B | 34.15B | 43.49B |
| Gross Profit | 9.38B | 9.36B | 9.60B | 8.71B | 6.46B | 5.68B |
| EBITDA | 9.16B | 8.32B | 8.38B | 8.23B | 12.79B | 5.00B |
| Net Income | 3.76B | 3.03B | 3.11B | 2.66B | 5.97B | 422.00M |
Balance Sheet | ||||||
| Total Assets | 119.88B | 122.69B | 114.53B | 111.17B | 108.75B | 99.61B |
| Cash, Cash Equivalents and Short-Term Investments | 7.54B | 8.86B | 5.78B | 8.37B | 8.78B | 6.04B |
| Total Debt | 41.67B | 43.19B | 39.23B | 39.79B | 37.98B | 36.52B |
| Total Liabilities | 61.89B | 65.11B | 60.15B | 61.52B | 61.78B | 57.76B |
| Stockholders Equity | 57.99B | 57.57B | 54.38B | 49.64B | 46.97B | 41.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -675.00M | -1.10B | -2.21B | -5.57B | -3.45B |
| Operating Cash Flow | 0.00 | 5.90B | 8.51B | 5.16B | 6.14B | 2.02B |
| Investing Cash Flow | 0.00 | -7.81B | -10.11B | -6.72B | -4.17B | -4.45B |
| Financing Cash Flow | 0.00 | 3.30B | -1.28B | 1.14B | 791.00M | -597.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥247.46B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
72 Outperform | ¥352.18B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
65 Neutral | ¥593.27B | 12.46 | 8.51% | 2.96% | -2.82% | -50.73% | |
65 Neutral | ¥19.59B | -109.80 | ― | 1.33% | 1.70% | 1841.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥45.57B | 14.50 | ― | 2.17% | 4.37% | 54.12% | |
59 Neutral | ¥20.56B | 9.88 | ― | 0.81% | 1.24% | 19.78% |